A Phase I Study of GRN163L in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2012
At a glance
- Drugs Carboplatin; Imetelstat; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 24 Jan 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 24 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2011 Planned End Date changed from 1 Aug 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.